The unique properties of nickel oxide nanoparticles (NiO-NPs) distinguish it from traditional nickel containing materials, and enable its industrial application as an advanced nanomaterial. Despite the benefits, the in vivo toxicological studies on NiO-NPs have been mainly focused on its pulmonary pathology. However, NiO-NPs exposure via oral route and its subsequent toxic effects in exposed animals are still lacking. Hence, we evaluated the NiO-NPs oral toxicity in male Wistar rats. NiO-NPs induced significant increase in chromosomal aberrations (CAs), micronuclei (MN) formation and, DNA damage in rats. Flow cytometric analysis showed apoptosis, ROS generation and dysfunction of mitochondrial membrane potential (ΔΨm). Imbalance of antioxidant enzymes, along with histological alterations was found in liver. Taking together, these results unequivocally suggested that NiO-NPs induced toxicity was through cyto-genetic alterations, oxidative stress, apoptosis and liver toxicity. The western blotting data validated the interplay of p53 and MAPKAPK-2 signalling via activation of caspases 8, 3, cyto c, pro-apoptotic bax and anti-apoptotic bcl-2 proteins.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijbiomac.2017.07.032DOI Listing

Publication Analysis

Top Keywords

p53 mapkapk-2
8
nickel oxide
8
oxide nanoparticles
8
nio-nps induced
8
nio-nps
6
mapkapk-2 caspases
4
caspases regulate
4
regulate nickel
4
nanoparticles induce
4
induce cell
4

Similar Publications

Long non-coding RNA MAGEA4-AS1 binding to p53 enhances MK2 signaling pathway and promotes the proliferation and metastasis of oral squamous cell carcinoma.

Funct Integr Genomics

September 2024

Peking University Shenzhen Hospital Clinical College, The Fifth School of Clinical Medicine, Anhui Medical University, Hefei, Anhui, 230032, China.

Article Synopsis
  • Long non-coding RNA MAGEA4-AS1 is found to be up-regulated in oral squamous cell carcinoma (OSCC) tissues, suggesting its potential role as a biomarker for the disease.
  • Research methods included bioinformatics analysis, quantitative PCR, and various cellular assays to study the effects of MAGEA4-AS1 on OSCC cell behaviors like proliferation, migration, and invasion.
  • The study revealed that MAGEA4-AS1 interacts with the p53 protein and enhances MK2 gene transcription, ultimately promoting OSCC cell growth and metastasis through specific signaling pathways.
View Article and Find Full Text PDF

A Novel cytarabine analog evokes synthetic lethality by targeting MK2 in p53-deficient cancer cells.

Cancer Lett

January 2021

College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea. Electronic address:

Article Synopsis
  • Some cancer drugs don't work well on cancer cells that have problems with a protein called p53, especially in certain types of blood cancers.
  • A new drug called F-Se-Ara-C is really good at killing prostate cancer cells that lack p53 by messing with another protein called MK2, which is important for how cells deal with damage.
  • When F-Se-Ara-C is used with another cancer drug called cabozantinib, they work even better together to fight these tough prostate cancer cells.
View Article and Find Full Text PDF

Accumulating evidence suggests that the senescence-messaging secretome (SMS) factors released by senescent cells play a key role in cellular senescence and physiological aging. Phenomenon of the senescence induction in human endometrium-derived mesenchymal stem cells (MESCs) in response to SMS factors has not yet been described. In present study, we examine a hypothesis whether the conditioned medium from senescent cells (CM-old) may promote premature senescence of young MESCs.

View Article and Find Full Text PDF

The unique properties of nickel oxide nanoparticles (NiO-NPs) distinguish it from traditional nickel containing materials, and enable its industrial application as an advanced nanomaterial. Despite the benefits, the in vivo toxicological studies on NiO-NPs have been mainly focused on its pulmonary pathology. However, NiO-NPs exposure via oral route and its subsequent toxic effects in exposed animals are still lacking.

View Article and Find Full Text PDF

The use of progesterone following brain injury has a controversial history. On one hand, some lab-based models have showed progesterone as being neuroprotective, but on the other, clinical trials have showed quite the opposite. One of many complaints that arose from this discrepancy was the lack of a diverse pool of animal models and paradigms employed during the preclinical phase.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!